TARA — Protara Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Protara Therapeutics Says Clinical Success Achieved With One Or Two Doses Of TARA-002 In 88% Of Patients
Protara Therapeutics Q3 net loss widens
Brief: Protara Therapeutics Q3 EPS USD -0.31
Brief: Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Protara Therapeutics' Q2 net loss widens
Protara Therapeutics Inc expected to post a loss of 40 cents a share - Earnings Preview
Brief: Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Protara Therapeutics Announces Appointment Of William Conkling As Chief Commercial Officer
Protara Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Protara Therapeutics Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Protara Therapeutics Completed Approximately $100 Million Public Offering, Extending Runway Into 2027
U.S. STOCKS ON THE MOVE-CoreCivic, Alphabet, Vail Resorts
U.S. STOCKS ON THE MOVE-CleanSpark, MoneyLion, CoreCivic
U.S. STOCKS ON THE MOVE-Boeing, Alaska Air, Centene
Protara Therapeutics down after pricing $100 mln stock offering
Brief: Protara Prices Public Offering Of 13.69 Mln Shares At $6.25 Per Share
Protara Therapeutics slides after unveiling stock deal
Brief: Protara Announces Proposed Public Offering
U.S. STOCKS ON THE MOVE-Uber, Tesla, LendingTree